CD70 and nonpapillary renal cell carcinoma: In order to increase the specificity of HIF2α siRNA delivery to ccRCC cells, PAMs were functionalized with a targeting ligand capable of binding to CD70, a transmembrane protein reported to be highly expressed in ccRCCs [29,30].